Alpine Woods Capital Investors Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Medtronic
MDT
|
+$5.53M |
| 2 |
Eli Lilly
LLY
|
+$4.4M |
| 3 |
Abbott
ABT
|
+$3.64M |
| 4 |
Truist Financial
TFC
|
+$3.08M |
| 5 |
International Flavors & Fragrances
IFF
|
+$2.96M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$27.6M |
| 2 |
Steel Dynamics
STLD
|
+$4.02M |
| 3 |
Clorox
CLX
|
+$3.32M |
| 4 |
Constellation Brands
STZ
|
+$2.9M |
| 5 |
Mastercard
MA
|
+$2.55M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 20.43% |
| 2 | Financials | 14.1% |
| 3 | Industrials | 13.6% |
| 4 | Healthcare | 12.95% |
| 5 | Consumer Discretionary | 6.29% |
Similar funds
Alpine Woods Capital Investors's Q2 2026 Portfolio in Review
As of Q2 2026, Alpine Woods Capital Investors held 253 positions worth $460M, up 10% from $417M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Alpine Woods Capital Investors withdrew a net $18.9M in Q2 2026, closing 33 positions and reducing 77 holdings. Its most notable exit was Clorox, an estimated $3.32M position sold in full.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 23% a quarter earlier, followed by Financials and Industrials.
Against the trend, Alpine Woods Capital Investors opened a new position in Medtronic worth $5.36M.
- Alpine Woods Capital Investors's largest Q2 2026 buy was Medtronic: 68,491 shares worth $5.36M.
- Alpine Woods Capital Investors added most to Eli Lilly in Q2 2026, an estimated $4.4M increase.
- Alpine Woods Capital Investors's biggest Q2 2026 reduction was NVIDIA, cutting an estimated $27.6M.
- Alpine Woods Capital Investors fully exited Clorox in Q2 2026, selling an estimated $3.32M.
- Alpine Woods Capital Investors's ten largest holdings make up 25% of its $460M portfolio in Q2 2026.
- Alpine Woods Capital Investors opened 54 new positions and closed 33 in Q2 2026.
- Alpine Woods Capital Investors's portfolio value rose 10% quarter-over-quarter to $460M.
Based on Alpine Woods Capital Investors's 13F filing for Q2 2026, filed 7 Aug 2026.